Sequencing for antimicrobial resistance surveillance
22 April 2022
The Foundation for Innovative New Diagnostics (FIND) published a report on “Sequencing for antimicrobial resistance surveillance,” which highlights the importance of genomic sequencing in AMR surveillance; provides examples of next-generation sequencing technologies, workflows, and databases; and discusses the potential of culture-free sequencing.
Further reading: FIND
Author(s): FIND
Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
